|
인쇄하기
취소
|
Green Cross and Pfizer Korea on strategic alliance for Genotropin.
Published: 2005-08-30 06:59:00
Updated: 2005-08-30 06:59:00
Green Cross agreed a business alliance with Pfizer for the distribution of Genotropin, the top human growth hormone product in the world for the treatment of the small baby for gestational age (SGA), a rare disease called Prader-Willi syndrome (PWS). The product will be launched to the market this month.
The strategic alliance with Green Cross seems to attribute to the Pfizer's recognition ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.